The use of catalpol (Cat) can increase the expression of adenosine 5′-monophosphate (AMP)-activated protein kinase (AMPK) and SIRT1, effectively inhibit pyroptosis in podocytes, and improve the abnormal structure and function in kidney of DN (Chen et al., 2020b). Here, SIRT1 is linked to liver dysplastic nodule.